Europese Unie - Nederlands - EMA (European Medicines Agency)

novartis europharm limited  - vildagliptin, metformine hydrochloride - diabetes mellitus, type 2 - geneesmiddelen die worden gebruikt bij diabetes - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pi pharma - vildagliptine; metforminehydrochloride - filmomhulde tablet - 50 mg - 850 mg - vildagliptine 50 mg; metforminehydrochloride 850 mg - metformin and vildagliptin

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pi pharma - vildagliptine; metforminehydrochloride - filmomhulde tablet - 50 mg - 1000 mg - vildagliptine 50 mg; metforminehydrochloride 1000 mg - metformin and vildagliptin

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pi pharma sa-nv - vildagliptine 50 mg; metforminehydrochloride 1000 mg - filmomhulde tablet - metformin and vildagliptin